RECRUITING

UPLYFT For Lymphoma Survivors

Description

The main purpose of this study is to field test and pilot an intervention called UPLYFT (Understand and Prevail: Lymphoma Fear of Recurrence Therapy) that includes information about lymphoma survivorship and tools to improve quality of life and reduce lymphoma-related worries among lymphoma survivors.

Conditions

LymphomaSurvivorship
Talk to us

Related Conditions:

LymphomaSurvivorship

Study Overview

On this page

Study Details

Study overview

The main purpose of this study is to field test and pilot an intervention called UPLYFT (Understand and Prevail: Lymphoma Fear of Recurrence Therapy) that includes information about lymphoma survivorship and tools to improve quality of life and reduce lymphoma-related worries among lymphoma survivors.

An Intervention for Fear of Cancer Recurrence for Lymphoma Survivors

UPLYFT For Lymphoma Survivors

Condition
Lymphoma
Intervention / Treatment

-

Contacts and Locations

Boston

Dana-Farber Cancer Institute, Boston, Massachusetts, United States, 02215

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Diagnosis of lymphoma (indolent non-Hodgkin lymphoma, aggressive non-Hodgkin lymphoma, or classic Hodgkin lymphoma)
  • * Age ≥ 18 years
  • * Interval of 3 months to 24 months from completion of first-line treatment
  • * In complete remission after first line of treatment
  • * Clinically significant FCR (score of ≥ 16 on the validated FCR Inventory-Severity Subscale \[FCRI-SS).
  • * Access to computer (for videoconferencing)
  • * Lymphoma clinicians ≥ 1 year from oncology fellowship completion OR mental health clinicians (psychologists, social workers, psychiatrists) ≥ 1 year from completion of clinical training.
  • * Longitudinal clinical care for patients with lymphoma by oncologists OR provision of care for patients with cancer by mental health clinicians
  • * Age \< 18 years
  • * Concurrent other malignancy
  • * Patients with uncontrolled/untreated psychotic disorders or untreated bipolar and borderline personality disorder (as ascertained from medical record screen).
  • * Age \< 18 years
  • * Concurrent other malignancy
  • * Patients with uncontrolled/untreated psychotic disorders or untreated bipolar and borderline personality disorders (as ascertained from medical record screen).
  • * Our study will exclude members of the following special populations:
  • * Adults unable to consent
  • * Individuals who are not yet adults (infants, children, teenagers)
  • * Pregnant women
  • * Prisoners

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Dana-Farber Cancer Institute,

Oreofe O Odejide, MD, PhD, PRINCIPAL_INVESTIGATOR, Oreofe_Odejide@dfci.harvard.edu

Study Record Dates

2025-04-30